Merck Aktie
WKN DE: A0YD8Q / ISIN: US58933Y1055
12.02.2025 14:36:21
|
Neuphoria To Receive $15 Mln Milestone Payment From Merck; Stock Up In Pre-market
(RTTNews) - Neuphoria Therapeutics Inc. (NEUP), a late-stage biotechnology company, Wednesday announced that a $15 million milestone payment is due from Merck & Co., Inc. (MRK).
Shares of Neuphoria Therapeutics are increasing by 20% in the pre-market trading.
Neuphoria has reached its second milestone in its partnership with Merck, earning a $15 million payment.
The agreement allows Neuphoria to receive up to $450 million in future milestone payments for developing and commercializing multiple drug candidates, along with royalties on sales of any approved medicines.
Merck has started a Phase 2 clinical trial by name - NCT06721156 to test the safety and effectiveness of MK-1167, a drug that enhances a7 nicotinic acetylcholine receptors, for treating Alzheimer's disease symptoms. This trial has triggered a payment.
In the pre-market trading, Neuphoria is 20.90% higher at $5.34 on the Nasdaq.
In the pre-market trading, Merck is 0.09% higher at $86.59 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Merck Co.mehr Nachrichten
30.06.25 |
Dow Jones-Handel aktuell: Dow Jones klettert zum Ende des Montagshandels (finanzen.at) | |
30.06.25 |
Starker Wochentag in New York: Dow Jones klettert am Montagnachmittag (finanzen.at) | |
30.06.25 |
Montagshandel in New York: Dow Jones notiert im Plus (finanzen.at) | |
30.06.25 |
Aufschläge in New York: Dow Jones-Börsianer greifen zum Start des Montagshandels zu (finanzen.at) | |
27.06.25 |
Börse New York: Letztendlich Gewinne im Dow Jones (finanzen.at) | |
27.06.25 |
Pluszeichen in New York: Dow Jones bewegt sich nachmittags im Plus (finanzen.at) | |
27.06.25 |
Starker Wochentag in New York: So bewegt sich der Dow Jones am Mittag (finanzen.at) | |
27.06.25 |
Zuversicht in New York: Dow Jones zum Handelsstart in Grün (finanzen.at) |
Analysen zu Merck Co.mehr Analysen
Aktien in diesem Artikel
Merck Co. | 67,10 | 0,15% |
|